Physician profile
Li-Yu H Mitchell
NPI 1962432559
$4,015.94
in general payments reported to CMS, 2019-2025
18 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $768 · 2021: $1,085 · 2022: $686 · 2023: $763 · 2024: $138 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $885.37 | 2022-2025 | Xperience, Blastx, Surgx |
| Misonix INC | $833.85 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $660.69 | 2021-2023 | Iovera |
| Avanos Medical | $250.58 | 2020-2022 | |
| Heron Therapeutics, INC. | $222.21 | 2021-2022 | |
| Kci USA, INC. | $218.58 | 2019-2022 | |
| Smith+Nephew, INC. | $213.23 | 2020-2024 | Collagenase Santyl, Regranex |
| Tei Medical INC. | $158.83 | 2019 | |
| Acera Surgical, INC. | $152.37 | 2021-2024 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $141.47 | 2020 | |
| Octapharma USA, INC. | $103.00 | 2025 | Fibryga |
| Paratek Pharmaceuticals, INC. | $39.79 | 2024 | Nuzyra |
| Solventum Corporation | $33.28 | 2024 | V.A.C. Dermatac, Activ.A.C. |
| Bioventus LLC | $26.56 | 2022 | |
| Glaxosmithkline, LLC. | $21.43 | 2023 | Shingrix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $19.01 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Melinta Therapeutics, LLC | $18.22 | 2019 | |
| Bsn Medical INC | $17.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Li-Yu Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.